AI assistant
Ambu — Major Shareholding Notification 2010
Apr 7, 2010
3353_iss_2010-04-07_9a4c3dbc-89dc-4864-8349-254d9b382971.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Company announcement no. 06 2009/10 7 April 2010
Chr. Augustinus Fabrikker A/S increases its shareholding in Ambu
According to § 29 of the Danish Securities Trading Act (Værdipapirhandelsloven), we hereby report that today Chr. Augustinus Fabrikker A/S, Amaliegade 47, DK-1256 Copenhagen K has informed us that they have a shareholding of 792,598 B-shares of DKK 10 in Ambu A/S and subsequently possess 6.7% and have a voting right of 2.9%.
Further information: Lars Marcher, CEO, phone +45 5136 2490, e-mail: [email protected]
Ambu develops, produces and markets diagnostic and life-supporting devices to hospitals and rescue services. Ambu has three business areas: Airway Management, Patient Monitoring & Diagnostics and Emergency Care. The primary products are ventilation products for artificial respiration and electrodes for ECG recordings and neurophysiological examinations as well as manikins for first-aid training. Ambu's products are marketed worldwide. Exports account for 98% of revenue, and sales are handled via Ambu's foreign subsidiaries or via distributors. Ambu has approx. 1,600 employees, of whom 300 work in Denmark and 1,300 abroad.